Cytokinetics

Cytokinetics, Inc. is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and first-in-class muscle inhibitors as potential treatments for patients with debilitating diseases associated with impaired and/or declining muscle performance. Cytokinetics is a leader in the research of muscle biology, with over 60 publications, more than 50 clinical trials, and hundreds of issued patents, currently developing small molecule drug candidates specifically designed to impact muscle function and contractility.